Published in Ann Rheum Dis on October 01, 1983
Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener's granulomatosis. Rheumatol Int (2005) 0.86
Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature. Medicine (Baltimore) (2015) 0.82
Combined CNS and pituitary involvement as a primary manifestation of Wegener granulomatosis. Clin Rheumatol (2005) 0.79
Cranial diabetes insipidus caused by giant cell arteritis. Postgrad Med J (1988) 0.75
Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore) (1973) 4.89
Diabetes insipidus associated with Wegener's granulomatosis successfully treated with cyclophosphamide. N Engl J Med (1978) 1.03
Wegener's granulomatosis presenting as theumatoid arthritis (two cases). Proc R Soc Med (1976) 1.01
Destructive lesions of vertebral bodies in ankylosing spondylitis. Ann Rheum Dis (1972) 2.59
Intra-articular distension and steroids in the management of capsulitis of the shoulder. BMJ (1991) 1.93
Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91
Bronchodilatation after inhalation of the antihistamine clemastine. Thorax (1978) 1.76
Lymphoedema associated with active inflammatory arthritis in a patient with congenital lymphatic hypoplasia. Br J Rheumatol (1995) 1.55
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol (1995) 1.43
1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure. Lancet (1973) 1.43
Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflamatory agent. II. Clinical trial in patients with rheumatoid arthritis. Ann Rheum Dis (1969) 1.40
Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol (1998) 1.38
Case of Reiter's disease treated with lincomycin hydrochloride. Br Med J (1967) 1.37
Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation. BMJ (1998) 1.35
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
HLA in Behçet's disease. Lancet (1976) 1.26
Translocation of protein kinase C to a Triton-insoluble sub-cellular compartment induced by the lipophilic gold compound auranofin. Biochem Pharmacol (1988) 1.06
Clinical experience with Ibuprofen in the treatment of rheumatoid arthritis. Ann Rheum Dis (1969) 1.05
Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann Rheum Dis (1987) 1.02
Idiopathic hypercalciuria and hyperparathyroidism. Br Med J (1970) 1.01
Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. Biochem Biophys Res Commun (1986) 1.00
Familial hyperparathyroidism. Postgrad Med J (1966) 1.00
Zinc increases phorbol ester receptors in intact B-cells, neutrophil polymorphs and platelets. FEBS Lett (1989) 0.98
Projective drawings by children under repeated dental stress. ASDC J Dent Child (1971) 0.96
Molecular basis of activation and regulation of the phagocyte respiratory burst. Ann Rheum Dis (1987) 0.96
Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis. Br Med J (Clin Res Ed) (1981) 0.94
Coxsackie B infection and arthritis. Br Med J (Clin Res Ed) (1983) 0.93
Is chronic renal failure a risk factor for the development of erosive osteoarthritis? Ann Rheum Dis (1989) 0.93
Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes. Biochem Pharmacol (1986) 0.92
Clinical trials of intra-articular aspirin in rheumatoid arthritis. Lancet (1980) 0.90
Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflammatory agent. I. Serum concentration studies in healthy individuals and in patients with rheumatoid arthritis. Ann Rheum Dis (1969) 0.88
A pilot study of the economic cost and clinical outcome of day patient vs inpatient management of active rheumatoid arthritis. Br J Rheumatol (1994) 0.86
1-alphahydroxycholecalciferol in chronic renal failure. Studies of the effect or oral doses. Ann Intern Med (1976) 0.86
Functional defects of monocyte C3b receptor-mediated phagocytosis in rheumatoid arthritis (RA): evidence for an association with the appearance of a circulating population of non-specific esterase-negative mononuclear phagocytes. Ann Rheum Dis (1983) 0.85
Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1984) 0.84
Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes. Ann Rheum Dis (1986) 0.84
Parathyroid function after 131-I therapy for hyperthyroidism. Clin Sci (1965) 0.83
Inhibition of epidermal growth factor binding to HeLa cells by auranofin. Biochem Pharmacol (1987) 0.83
Calcium ionophore A23187 enhances human neutrophil superoxide release, stimulated by phorbol dibutyrate, by converting phorbol ester receptors from a low- to high-affinity state. FEBS Lett (1987) 0.83
Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: some preliminary observations. Curr Med Res Opin (1977) 0.83
Medically unexplained symptoms in patients referred to a specialist rheumatology service: prevalence and associations. Rheumatology (Oxford) (2003) 0.82
Abnormal vitamin D metabolism in cirrhosis. Gut (1978) 0.82
Quantifying the burden of emotional ill-health amongst patients referred to a specialist rheumatology service. Rheumatology (Oxford) (2003) 0.81
Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils. Biochem Pharmacol (1990) 0.81
The effects of Mg2+, Ca2+, ATP and cyclic 3',5'-AMP on the hormone-sensitive lipase of adipose tissue. Biochim Biophys Acta (1970) 0.81
Cervical spine surgery in patients with rheumatoid arthritis: an appraisal. Ann Rheum Dis (1996) 0.81
Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids. Ann Rheum Dis (1984) 0.81
An audit of methotrexate and folic acid for rheumatoid arthritis. Experience from a teaching centre. Br J Rheumatol (1995) 0.81
Ventricular tachycardia after disopyramide. Lancet (1978) 0.80
IgG (kappa) paraproteinaemia and arthritis. Br J Rheumatol (1987) 0.80
An evaluation of the Health Assessment Questionnaire (HAQ) in a long-term longitudinal follow-up of disability in rheumatoid arthritis. Br J Rheumatol (1994) 0.80
Vitamin D metabolism in acute and chronic cholestasis. Gut (1979) 0.79
Enhancement of protein kinase C-mediated EGF receptor phosphorylation by auranofin. Scand J Rheumatol (1988) 0.78
Effects of piroxicam on superoxide generation, phospholipid methylation and leukotriene production by human blood mononuclear cells. J Rheumatol (1987) 0.78
Inhibition of protein kinase C activity by the antirheumatic drug auranofin. Biochem Pharmacol (1989) 0.78
Enterohepatic circulation of vitamin D: a reappraisal of the hypothesis. Lancet (1984) 0.78
Transient presence in serum of an atypical alkaline phosphatase. Clin Chim Acta (1976) 0.78
Premature development of erosive osteoarthritis of hands in patients with chronic renal failure. Ann Rheum Dis (1990) 0.77
Impact of fluoridation in a private pedodontic practice: thirty years later. ASDC J Dent Child (1981) 0.77
Re: Quality of life measures. Br J Rheumatol (1997) 0.77
Sjögren's syndrome, vasculitis, and cryoglobulinaemia associated with a monoclonal IgM (kappa) paraprotein with rheumatoid factor activity. Ann Rheum Dis (1987) 0.77
Is inosine pranobex contraindicated in autoimmune disease? Br Med J (Clin Res Ed) (1988) 0.77
Parathyroid function in spontaneous primary hypothyroidism. J Endocrinol (1968) 0.77
Auranofin increases the affinity of phorbol dibutyrate receptors in chronic lymphocytic leukemia cells (B cells). J Immunol (1987) 0.76
Reactive arthritis--infectious agents and genetic susceptibility in the pathogenesis of sero-negative arthritis. Scott Med J (1983) 0.76
Does economic evaluation have anything to offer the rheumatologist? Rheumatology (Oxford) (1999) 0.76
Pseudothrombophlebitis of the thigh: unusual complication of repeated aspiration of recurrent knee effusion. J R Soc Med (1986) 0.75
Multiple endocrine adenomatosis (Type I) and familial hyperparathyroidism. Postgrad Med J (1978) 0.75
Multiple subaxial subluxation of cervical spine: a side effect of corticosteroids? Br Med J (Clin Res Ed) (1985) 0.75
Anti-arthritic propionic acid derivatives and 17-oxosteroid measurements--a direct interference. Postgrad Med J (1985) 0.75
Spinal complications of ankylosing spondylitis. J R Soc Med (1986) 0.75
Screening for antimalarial maculopathy in rheumatology clinics. Br Med J (Clin Res Ed) (1985) 0.75
Diagnostic criteria for work-related upper limb disorders. Br J Rheumatol (1997) 0.75
Ultraviolet light: an effective treatment of osteomalacia in malabsorption. Br Med J (1978) 0.75
Sclerosing injections in patients with chronic low back pain. Rheumatology (Oxford) (2000) 0.75
Quantitative sacroiliac scintiscanning: a sensitive and objective method for assessing efficacy of nonsteroidal, anti-inflammatory drugs in patients with sacroiliitis. Ann Rheum Dis (1984) 0.75
Combination therapy in rheumatoid arthritis. Rheumatology (Oxford) (1999) 0.75
Re: Measuring outcomes in rheumatoid arthritis--which measures are suitable for routine use? Br J Rheumatol (1997) 0.75
HLA in multiple endocrine adenomatosis (type I). Tissue Antigens (1979) 0.75
Auranofin enhances phosphorylation of putative substrates of protein kinase C in human platelets. Biochem Pharmacol (1988) 0.75
Clinical experience with ibuprofen in rheumatoid arthritis. Schweiz Med Wochenschr (1971) 0.75
Effect of corticosteroid therapy on blood monocyte superoxide generation in rheumatoid arthritis: studies in vitro and ex vivo. Br J Rheumatol (1986) 0.75
[1 alpha-hydroxycholecalciferol in treatment of renal osteodystrophy]. J Urol Nephrol (Paris) (1974) 0.75
The general management of rheumatoid arthritis. Practitioner (1972) 0.75
Megaloblastic anaemia and vision. Lancet (1967) 0.75
The effect of ACTH on hormone excretion in patients with rheumatoid arthritis. Scott Med J (1967) 0.75
Vasculitis, Raynaud's phenomenon and polyarthritis associated with gemfibrozil therapy. Br J Rheumatol (1993) 0.75
Inhibitory effect of follicle stimulating hormone on parathormone in the mouse--a possible explanation of postmenopausal osteoporosis. Isr J Med Sci (1982) 0.75
Vasculitis associated with herbal preparation containing Passiflora extract. Br J Rheumatol (1993) 0.75
Calcium ionophore A23187 primes human B-cells for activation by phorbol dibutyrate by converting receptors for phorbol dibutyrate from a low to high affinity state. Biochem Biophys Res Commun (1986) 0.75
Another cause of painful swelling in the calf in patients with rheumatoid arthritis. Br J Rheumatol (1986) 0.75
Osteomalacia in ureterosigmoidostomy: healing by correction of the acidosis. Br J Urol (1980) 0.75
Phorbol 12-myristate 13-acetate, A23187 and L-adrenaline inhibit phospholipid methylation in human monocytes and lymphocytes. Inhibition is independent of oxyradical production and phospholipid hydrolysis. Free Radic Biol Med (1990) 0.75
Intra-cranial haemorrhage from drug abuse. Br J Clin Pract (1986) 0.75
Destructive spondylarthropathy and chronic renal failure. Arthritis Rheum (1988) 0.75
Modulation of human neutrophil LTA hydrolase activity by phorbol myristate acetate. Biochem Biophys Res Commun (1987) 0.75
Erdheim-Chester disease associated with hydrocalycosis and arthropathy. Arthritis Rheum (1988) 0.75
The effects of anti-inflammatory and anti-rheumatic drugs on phagocyte cell function. Agents Actions Suppl (1988) 0.75
Destructive lesions of vertebral bodies in ankylosing spondylitis. Ann Rheum Dis (1971) 0.75